Application of pharmaceutical QbD for enhancement of the solubility and dissolution of a class II BCS drug using polymeric surfactants and crystallization inhibitors: development of controlled-release tablets.

Application of pharmaceutical QbD for enhancement of the solubility and dissolution of a class II BCS drug using polymeric surfactants and crystallization inhibitors: development of controlled-release tablets.

Item
http://www.wikidata.org/entity/Q38312135
Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia.Application of quality by design to the process development of botanical drug products: a case study.Experimental and computational studies of physicochemical properties influence NSAID-cyclodextrin complexation.Continuous production of fenofibrate solid lipid nanoparticles by hot-melt extrusion technology: a systematic study based on a quality by design approach.Rapidly absorbed orodispersible tablet containing molecularly dispersed felodipine for management of hypertensive crisis: development, optimization and in vitro/in vivo studies.Xylitol as a potential co-crystal co-former for enhancing dissolution rate of felodipine: preparation and evaluation of sublingual tablets.Transfersomal lyophilized gel of buspirone HCl: formulation, evaluation and statistical optimization.Respirable controlled release polymeric colloid (RCRPC) of bosentan for the management of pulmonary hypertension: in vitro aerosolization, histological examination and in vivo pulmonary absorption.Scientific, statistical, practical, and regulatory considerations in design space development.Developing a quality by design approach to model tablet dissolution testing: an industrial case study.Design and development of novel lipid based gastroretentive delivery system: response surface analysis, in-vivo imaging and pharmacokinetic study.
P2860

Application of pharmaceutical QbD for enhancement of the solubility and dissolution of a class II BCS drug using polymeric surfactants and crystallization inhibitors: development of controlled-release tablets.

Item
http://www.wikidata.org/entity/Q38312135
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Application of pharmaceutical ...... of controlled-release tablets.
@en
type
label
Application of pharmaceutical ...... of controlled-release tablets.
@en
prefLabel
Application of pharmaceutical ...... of controlled-release tablets.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P6179
P698
P932
P356
P1433
P1476
Application of pharmaceutical ...... of controlled-release tablets
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P6179
P698
P932